Infinimmune: Funding, Investors & Team (Sep 2026)
Infinimmune develops human-derived antibody medicines using B-cell sequencing, computational modeling, and antibody engineering technology.
Infinimmune has raised $75.0M across 1 funding round on record, the most recent a Series A of $75.0M announced in Aug 2026.
That round is above the $7.5M median round size for United States companies tracked on FundedIQ over the last two years.
Infinimmune Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Infinimmune Funding Rounds
Infinimmune Investors
18 investors are recorded in total; the 5 named above are those the record identifies.
Infinimmune Founders and Leadership Team
Contact details for the Infinimmune team: 2 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Infinimmune Funding in Context
Infinimmune's latest round of $75.0M is above the median round in United States. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Infinimmune in Artificial Intelligence and Alameda
Companies Similar to Infinimmune
ClinicFlow is an AI voice agent that answers, schedules, and triages phone calls 24/7 for orthopedic, spine,…
Rubi.ai is an AI-powered deal engine for private markets, automating sourcing, screening, CRM, and…
Phinge® Creating Netverse®, Patented App-less, Integrated Technologies & Verifed Platform & AI With…
Based in SF & NY we are building the technology stack to solve the experience, trust, and transparency…
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
HiFi Bridge is a cryptocurrency payments platform that allows customers to buy and sell cryptocurrencies,…
Energy Domain is a platform that offers market analysis, an innovative auction system, and promotional…
AI + Open Source OS for MSPs
Steribite is a medical device company focused on developing unique, disposable products that improve patient…
Post ads, Find, Buy and Rent things.
FlexEtc offers flexible warehouse, office, and coworking spaces with all-inclusive pricing and terms for…
Infinimmune Funding FAQs
What does Infinimmune do?
Infinimmune develops human-derived antibody medicines using B-cell sequencing, computational modeling, and antibody engineering technology.
How much funding has Infinimmune raised?
Infinimmune has raised $75.0M across 1 round on record. The most recent is a Series A of $75.0M announced in Aug 2026.
When did Infinimmune last raise funding?
Infinimmune's most recent funding round on record is a Series A of $75.0M, announced in Aug 2026.
Who has invested in Infinimmune?
Investors on record for Infinimmune include RA Capital Management, Pear VC, Playground Global, Goldcrest Capital, Civilization Ventures. FundedIQ records 18 investors in total.
Who founded Infinimmune?
FundedIQ lists Wyatt McDonnell (Co-Founder and CEO), Michael Gibbons (Co-Founder) at Infinimmune.
Where is Infinimmune headquartered?
Infinimmune is based in Alameda, United States.
How many employees does Infinimmune have?
Infinimmune is in the 1-10 employee band.
When was Infinimmune founded?
Infinimmune was founded in 2022.
About FundedIQ's Infinimmune Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Infinimmune is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.